CA2037727A1 - Removing lps pyrogen from aqueous solution - Google Patents
Removing lps pyrogen from aqueous solutionInfo
- Publication number
- CA2037727A1 CA2037727A1 CA 2037727 CA2037727A CA2037727A1 CA 2037727 A1 CA2037727 A1 CA 2037727A1 CA 2037727 CA2037727 CA 2037727 CA 2037727 A CA2037727 A CA 2037727A CA 2037727 A1 CA2037727 A1 CA 2037727A1
- Authority
- CA
- Canada
- Prior art keywords
- polymyxin
- lps
- cloth
- hydrophobic
- filter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002510 pyrogen Substances 0.000 title claims abstract description 41
- 239000007864 aqueous solution Substances 0.000 title claims abstract 7
- 239000004744 fabric Substances 0.000 claims abstract description 49
- 108010040201 Polymyxins Proteins 0.000 claims abstract description 41
- 108010093965 Polymyxin B Proteins 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 30
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 29
- 229920000024 polymyxin B Polymers 0.000 claims abstract description 27
- 229960005266 polymyxin b Drugs 0.000 claims abstract description 27
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 19
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 19
- 229920001184 polypeptide Polymers 0.000 claims abstract description 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 10
- 229920000728 polyester Polymers 0.000 claims description 21
- -1 polyethylene Polymers 0.000 claims description 16
- 239000004743 Polypropylene Substances 0.000 claims description 8
- 229920001155 polypropylene Polymers 0.000 claims description 8
- 239000004677 Nylon Substances 0.000 claims description 6
- 229920001778 nylon Polymers 0.000 claims description 6
- 239000004698 Polyethylene Substances 0.000 claims description 5
- 229920000573 polyethylene Polymers 0.000 claims description 5
- 239000000835 fiber Substances 0.000 claims description 4
- 239000002158 endotoxin Substances 0.000 description 56
- 229920006008 lipopolysaccharide Polymers 0.000 description 54
- 239000000243 solution Substances 0.000 description 33
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000004772 Sontara Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229920000936 Agarose Polymers 0.000 description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 description 4
- SBKRTALNRRAOJP-BWSIXKJUSA-N N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide (6S)-N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide sulfuric acid Polymers OS(O)(=O)=O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O SBKRTALNRRAOJP-BWSIXKJUSA-N 0.000 description 3
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 229960003548 polymyxin b sulfate Drugs 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 108010078777 Colistin Proteins 0.000 description 2
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 2
- 229930195711 D-Serine Natural products 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- XDJYMJULXQKGMM-RVYUQJQSSA-N colistin A Chemical compound CC[C@@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O XDJYMJULXQKGMM-RVYUQJQSSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- BLCJBICVQSYOIF-UHFFFAOYSA-N 2,2-diaminobutanoic acid Chemical compound CCC(N)(N)C(O)=O BLCJBICVQSYOIF-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 241000239218 Limulus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000194105 Paenibacillus polymyxa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229960003346 colistin Drugs 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 108010072542 endotoxin binding proteins Proteins 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- YKQOSKADJPQZHB-YNWHQGOSSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1s)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Polymers CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O YKQOSKADJPQZHB-YNWHQGOSSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000003186 pharmaceutical solution Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Abstract
ABSTRACT OF THE DISCLOSURE
A method for removing LPS pyrogens from aqueous solutions is provided herein. The method comprises passing such aqueous solution through a filter comprising a macroporous hydrophobic cloth which has been coated with an oligopeptide, e.g., a hydrophobic polypeptide, or a polymyxin, preferably polymyxin B, thereby to have such oligopeptide, e.g., a hydrophobic polypeptide, or a polymyxin, preferably polymyxin B, stably bound thereto, whereby LPS pyrogens are adhered to the filter.
A method for removing LPS pyrogens from aqueous solutions is provided herein. The method comprises passing such aqueous solution through a filter comprising a macroporous hydrophobic cloth which has been coated with an oligopeptide, e.g., a hydrophobic polypeptide, or a polymyxin, preferably polymyxin B, thereby to have such oligopeptide, e.g., a hydrophobic polypeptide, or a polymyxin, preferably polymyxin B, stably bound thereto, whereby LPS pyrogens are adhered to the filter.
Description
- 2 3 ~ ~ 7 2 7 : 1 This invention relates to the removal of pyrogens from solutions.
Pyrogens are toxic substances which cause fever in humans as well as in other animals, and which display toxicity to many living cell types, e.g. mammalian cells maintained ln vitro in cell or tissue cultures.
Pyrogens must be removed from solutions or any product destined for injection (e.g. pharmaceuticals, e.g.
injectable saline, pharmacological drugs and lo antibiotics~ into humans or animals, or for use in the preparation of culture media for the propagation or mammalian cell or tissue cultures. Gram-negative ; bacterial lipopolysaccharides (LPS) (also termed "endotoxins"), a major constituent of the outer cell wall, are the main types of pyrogens encountered.
` Almost all Gram-negative bacteria found in nature - produce pyrogenic LPS, including (among numerous ~ others), Escherichia coli and Salmonella species.
-`~ Several methods have been developed for the removal of LPS pyrogens from solutions, including one method which is based on the affinity of the antibiotic ~ polymyxin B for the LPS molecule. Issekutz, in the .~ Journal of Immunological Methods (1983) 61: 275 - 281, described the use of polymyxin B covalently bound to agarose ~eads to remove LPS pyrogens from solutions in a packed column operation. However, the method for preparing the polymyxin-agarose support is laborious cl and may be subject to batch variations, si~ce it .~ involves chemical treatment in order to immobilize the polymyxin B on the agarose beads, and the extent and uniformity of the treatment may vary from batch-to-~'r batch. Such method is also costly, since the -~ ~aterials, quality control measures and chemical ~-1 treatments required are relatively expensive. Indeed, 3S products currently available on the market to remove pyrogens ~rom solutions are costly, and this cost in : 'f~ ~
.' :
., :.. , ' ~. . , : . , ' ' '.`~' . ' . . .. - ' ' ' ' ' ' . ' ' . ' . .' . , ~ ' ',: ' : .
,.. ' .. .'., ~' ... : ~ ' .. -,': .. ' . , ' ' ", - ' :
7 ~ ~
turn affects the cost of the final products (e.g.
pharmaceuticals) from which pyrogens must be removed.
Boehringer Mannheim has now provided polymyxin B-SEPHAROSE, namely polymyxin B bound covalently to 5SEPHAROSE 4B. This product is said to be available in gel form and is said to be able to remove endotoxin impurities. It is also said that the gel can be regenerated by washing with deoxycholate solutions.
This pyrogen removal agent su~fers from the same lodisadvantages as disclosed above with respect to the polymyxin B covalently bound to agarose beads. It is manifest that a commercially-attractive process cannot be conceived using this gel filter.
Alerchek Inc. has also now provided an affinity 15filter in the form of a derivatized PVC-silica composite with polymyxin B sulfate and an LPS binding co-peptide covalently immobilized to the silica.
Since this filter is microporous, filtering is effected using a tangential filter apparatus/ which is 20a more expensive technique.
An object of the broad aspect of this invention is the provision of a method for the removal of LPS
pyrogens fxom water in which the LPS pyrogen-removal agent can be prepared without the need for any 25chemical modification of the substrate used in such pyrogen removal.
An object of another aspect of this invention is the provision of a method for the removal of LPS pyrogens . from water in which the method for preparing such LPS
30pyrogen-removal agent is such that the quality of the LPS pyrogen-removal agent has minimal batch-to-batch variations.
An object of still another aspect of this invention is the provision of a method for the removal of LPS
~35pyrogens from ~ater in which the method for preparing -~such LPS pyrogen-removal agent is such that the LPS
, ., - , . . .
~ : . . -, . . ~ . .
stability of the LPS pyrogen-removal agent is enhanced.
An object of yet another aspect of this invention is the provision of a method for the removal of LPS
pyrogens from water in which the method is such that it enables the low cost preparation of such LPS
pyrogen-removal agent.
By a- broad aspect of this invention a method i5 provided for removing LPS pyrogens from an at~ueous solution which comprises passing such at~ueous solution through a filter consisting essentially of a macroporous hydrophobic cloth which has been coated with an oligopeptide, e.g. a polymyxin, preferably with polymyxin B, or with any other hydrophobic polypeptide, which is stably bound thereto.
- Polymyxin is an oligopeptide which has a high affinity for lipopolysaccharides (LPS) in aqueous buffers. Polymyxin is an antibody complex produced by Bacillus polymyxa:
'Y 1 2 L-DAB - D-X ~ L-Y
5 _ L-DAB -~L-Thr -~Z-~L-DAB
~-NH2 L-Thrt L-DA8- L-D
. ' = = I = ~
,," . y-NH2 'Y-NH2 DAB = ~ diaminobutyric acid ~ . .
~A Polymyxin B. Mixture of polymyxin~ Bl and B2.
~ 35 Polymyxin Bl. C56H~N16013 R = (+)-6-methyloctano-yl;
'~ X = phenylalanine; Y = leucine; Z = L-DAB.
~, PolYmyxin B2. C55~6N16013, R = 6-methylheptanoyl;
~, .
. 1 .
.
2 ~ 3 J 7 2 7 X = phenylalanine; Y = leucine; Z = L-DAB.
Polymyxin D1- CsoHs3N1s1s~ R = (+)-6-methyloctanoyl;
X ~ leucine; Y = threonine; Z = D-serine.
Polymyxin Dz~ C4~91N1sO,5. R = 6-mathylheptanoyl;
X = leucine; Y = threonone; Z = D-serine.
Colistin.
/L-DAB--D-L~u L-~ ,e~
L-D~a L-Thr ~ L-DA8 - L-DA8 1 0 = I = = I ~ ~ ~ :
; ~H2 ~-~2 L-Tllr-- L-D.~8~ L-D,~
~ H2 `~-~H2 DAB = o,~-diaminobutyric acJd .. .
Colistin A. Cs3H1ooN16013, polymyxin E1. R = (+)~6-methyloctanoyl.
; Polymyxin E C52H98N16O13. R = 6-methylheptanoyl.
The cloth is preferably formed from a hydrophobic fibre selected from the group consisting of polyester, polyethylene, polypropylene and nylon.
; It is preferred that the cloth be packed into an . .
upright cylindrical column fitted with a valve. The flow ratè used is from 25 to 200 ml/hr, but the rate preferably used is 50 ml/hr.
This invention also provides a filter comprising a macroporous hydrophobic cloth which has been coated with an oligopeptide, a hydrophobic polypeptide, or a ^ 30 polymyxin, thereby to have the oligopeptide, or the hydrophobic polypeptide the polymyxin stably bound thereto. Preferably the filter comprises a macroporous hydrophobic cloth which has been coated , with polymyxin B, thereby to have the polymyxin B
stably bound thereto. Still more preferably, the cloth is formed from a hydrophobic fibre selected from , . .
.~, .
. ...
:,~
., , :
~ . i . i ~ . , . .. . , , :
~ ~ 7 ri 2 1 the group consisting of polyester, polyethylene, polypropylene and nylon.
The term "macroporous" as applied to cloths when used herein is intended to mean textiles composed of hydrophobic synthetic polymeric fibres, which are either woven or non-woven into a physically structurally stable cloth of more than about 200 ~m thickness, such that the pores (i.e. spaces between the fibres) exceed about 20 ~m in diameter.
Macroporous cloths may be made substantially completely from synthetic fibres selected from the group consisting of polypropylene, polyethylene, nylon, and polyester.
Such macroporous cloths have the following characteristics: they can accommodate a larger volume of the oligopeptide, i.e. polymyxin, e.g. polymyxin B
per area; they have a larger surface area for binding to the oligopeptide, i.e. polymyxin, e.g. polymyxin B;
they have minimum flow resistance; and they have both strength and durability. Such macroporous cloths, by virtue of their hydrophobic characteristics, have been found to adsorb and absorb the oligopeptide, i.e.
polymyxin, e.g. polymyxin B since they provide a large surface area for the oligopeptide, i.e. polymyxin, e.g. polymyxin B ~apture. Macroporous cloths all have such minimum flow resistance.
Such macroporous hydrophobic cloths made of, e.g.
polypropylene and polyester, are readily commercially available and are moderately priced because of their large commercial demand as textiles and filters.
~acroporous 100% nylon cloth is commercially available ` as a generic product and may be acquired locally in the Ottawa, Canada area. Macroporous woven polyester cloth is commercially available as a generic product and may be acquired locally in the Ottawa, Canada area. Macroporous non-woven polypropylene filter cloth is available as a generic product and may be ' :
~ ., - . . . .
- ' . .:
;: ` - - . .
, 7 i~, ~
purchased from Aldrich Chemical Co. A variety of non-woven, macroporous polyester cloths may be obtained from DuPont, and are known by the trade-mark SONTARA.
One preferred embodiment of such SONTARA is SONTARA
5 81O0T~, which has the following chemical and physical characteristics.
Typical Physical Properties of SONTARA 8100 are:
(in English Units) U!JIT Tn'lC~NESSS~IE I G;lAEI ,.q~ OlD , .UU~ 'N ~ .q AIR ROLL SIZ`=
WEIGHT T_NSIL_ T--AP, D~URST ~ .IEA21UTr ~7-' ID COAQ
o:~ya i~) Imils) (Ibsl (Ib~ (P-i~ (CFMI~l~ in. 11n.
MO XD UO XD @ 05'~ ~,O) 0Ø yd S~yle .'~10tt~' Polyest~r - Frazier Air Permeability is described in ASTM D737-. 75, and is attached hereto as Appendix I.
20The term "hydrophobic" as applied to cloths when used herein is intended to mean that the cloths repel water, the degree of repelling being dependent on the - pore size and the inherent polymeric properties.
The term "non-woven" when referring to the cloth is 25intended to mean a cloth formed ~rom a random arrangement of natural or synthetic fibres by adhesives, heat and pressure, or needling techniques.
Polyester cloth can passively (hydrophobically) adsorb the oIigopeptide, i.e. plymyxin, e.g. polymyxin 303 using a simple coating procedure. Such -oligopeptide, i.e. polymyxin, e.g. polymyxin B-coated ~-cloth can effectively capture LPS antigens.
- Accordingly, by this invention it is now taught that -the oligopeptide, i.e. polymyxin, e.g. polymyxin B-35coated polyester cloth may be a suitable support in a method for the removal of LPS pyrogens from solutions.
-, ~. .
~.
., .
~772 ~ :
By the present invention, it has been found thatthe oligopeptide, i.e. polymyxin, e.g. polymyxin B-coated polyester cloth has several advantages over the use of other LPS pyrogen removal devices. Some advantages are (1) the ease with which polymyxin B-cloth can be prepared without the need for any chemical modifications of the cloth or the antibiotic;
(2) th`e minimum batch-to-batch variation in the guality of the oligopeptide, i.e. polymyxin, e.g.
polymyxin B-cloth preparation, due to the simple method for its preparation; (3) the stability of the oligopeptide, i.e. polymyxin e.g. polymyxin B-~ polyester cloth hydrophobic interaction; and (4) the -~ low cost of its preparation, which should help to reduce the commercial cost of pharmaceuticals or ~ther solutions to which it is applied.
It is also believed that other oligopeptides, e.g.
hydrophobic polypeptides which bind to LPS pyrogens would also bind to hydrophobic macroporous cloths to provide a filter for use in the method of this invention.
The following Examples are given with respect to the preparation of polymyxin B-coated cloth and the use of ` such cloth.
Polymyxin B sulfate (No. P-1004), Salmonella typhimurium lipopolysaccharide (LPS) (No. L-6511~ and ... .
-~ ~ the E-TOXATETM system for measuring LPS pyrogens (No.
210-A) were from Sigma Chemical Co.
Polyester cloths used were SONTARA obtained from ~; 30 DuPont and having the following characteristics:
: EXAMPLE A
Pre~aration of PolYmyxin-Coated Polyester Cloth ` All glassware used herein was de-pyrogenized by heating for 20 h at 250C~ Pyrogen-free distilled ' 35 water was used as a universal solvent.
Polyester cloth (DuPont, Sontara 8100~M) was cut into 6 x 6 mm segments and wetted by vigorously . ~i .. ; ' '. ', ' . ' ` ' . ' - - . -' . ' ' . ' ':: : ' ' . `., ' ' . ' ' :. .: ' . " ' "
: . , . ' , . . ` . .: ' ' ' ` ` . . :
i' ` '. ` : ' ', ' , ` ` ` . ::, ~ ~3 .~ h 1' sha~ing in doubly distilled water, and then blotted.
One gram of the cloth segments ("wet" weight) was placed in 5 ml of polymyxin B solution [10 mg polymyxin/ml in 0.01 M phosphate-buffered (pH 7 . 2~ -- 5 0.85% NaCl (PBS)] and incubated for 16 h at room temperature. The polymyxin-coated segments were then washed with 100 ml of PBS on a filter under suction and stored in P8S at 4C until use.
EXAMPLE I
Removal of_ LPS Pyroaens from Solution Usina Polymyxin-Coated Polyester Cloth one gram of polymyxin B-coated polyester cloth segments (prepared as Example A) was packed into a ' small disposable polypropylene QUIK-SEPTM column (Isolab. Inc., No. QS-U) fitted with a valve. A
solution of pyrogens consisting o~ Salmonella typhimurium LPS dissolved in PBS was then allowed to flow through the polymyxin B-cloth column by gravity flow, with the flow rate adjusted using the valve as requiredO The effluent from the column was c.ollected ', and its pyrogen content measured using the E-TOXATETM
~ kit for pyrogen detection according to the ','' manufacturer's directions.
EXAMPLE II
Effect of LPS Pyrogen Concentration on its Removal from Solution The ability of polymyxin B coated polyester cloth ~, to remove LPS pyrogens from solution was studied using ' polymyxin B-cloth packed into a column through which ' 30 the pyrogen solution could be "trickled" or filtered ', to effect the pyrogen removal. As an example, the removal of S. typhimurium LPS was studied.
Fifty millilitres of solutions containing various concentrations of S.,typhimurium LPS were passed at a ' 35 flow rate of 50 ml/h through a column packed with `' polymyxin B-cloth. The total effluent from the column was collected and then assayed for remaining LPS
' ':
. ~ .
':, ,,.: - . ' ~ ... . . ~ ,, - . , : . .
.. . , , ., . ,,, ~ , . . .. . .
. . . :, ., , .. , .. - ... : ~
-... : - . ~ :, .. . .. , .. , , . .. ~ ... ..
. . . ;: . :
., - , , .. . . . . . . . ..
J ri ~
pyrogen using the E-TOXATET~ kit. Table 1 shows that for input LPS concentrations of less than lO ~g/ml, the polymyxin B-cloth column efficiently removed the majority of the LPS from the solution. The LPS in the solution at an input concentration of 10 ~g/ml (or greater) might be more effectively removed by either decreasing the flow rate through the column or increasing the quantity of polymyxin B-cloth segments packed in the columnO
~ TABLE 1. Effect of LPS Pyroqen Concentration on its : Removal from Solution by Polymyxin-Coated Polyester Cloth : Input Effluent : 15 LPS Concentration LPS Concentration (~q/ml) (~q/ml) 0.1-1.0 2 < 0.05 ,~
1 < 0.05 0.1 < 0.05 EXAMPLE III
Effect of Flow Rate on the Removal of LPS Pyrogens ` from Solution .-It is expected that the rate at which the LPS
solution i5 passed through the polymyxin B-cloth `~ column will affect the efficiency of the column in . removing the LPS from solution. Therefore, the effect - of flow rate on LPS removal was studied.
Fifty millilitres of a 1 ~g/ml solution of LPS was 35 passed through the polymyxin B-cloth column at various flow rates, obtained by adjusting the valve on the .~ column as reguired. The effluent from the column was then collected and measured for LPS pyrogens as above.
Table 2 shows that a maximum flow rate of 50 ml/h achieved efficient removal of the LPS from solution, .~ -,.
.
. .
whereas flow rates greater than this resulted in some LPS remaining in the effluent solution. Since high flow rates would be desirable from the point of view of the time saved in LPS removal, the use of longer columns with more polymyxin B-cloth packing may be necessary to achieve more effective removal of the LPS
at the desired higher flow rates.
TABL~ 2. Effect of Flow Rate on the Removal of LPS
from Solution by Polymyxin-Cloth Flow Rate Effluent (ml/h LPS Concentration - (~q/ml) 200 0.1-10 - 15 100 0.1 < 0-05 < 0.05 .
These results demonstrate that polymyxin B-coated 20 polyester cloth is applicable to the removal of 1PS -pyrogens from solutions. This system was efficient, rapid and inexpensive, which should make it a commercially attractive alternative to other systems in current use. -~
Thus, by the present invention, macroporous polyester cloth coated with polymyxin B sulfate was packed into small plastic disposable columns, and solutions of phosphate-buffered saline containing various concentrations of S. tY~himurium 30 lipopolysaccharide pyrogens were filtered through the packed columns by gravity flow. Passage of the pyrogen solutions through the packed columns at a flow rate of 50 ml/h effectively removed the majority of the pyrogens from the solutions, as determined by the ', 35 limulus amoebocyte lysate detection system. Polymyxin B-coated macroporous hydrophobic cloth should be useful for the removal of pyrogens from pharmaceutical solutions (e.g. injectable solutions), cell culture .
.~ .
' ' . , ' ~ ' :
2 1~ ~ r~J 7 ~ ~
media and other solutions where the presence of pyrogens is undesirable.
"
... .
-~., .~' , ' ,i' .
. .
:,~
~ :
~ .
.~
~' ` .
. ~ . .
;:
~i i ~
~i . .
~ !
'`' . ~ . ~. ' , ' , ' ' . ' ' '"' ' '
Pyrogens are toxic substances which cause fever in humans as well as in other animals, and which display toxicity to many living cell types, e.g. mammalian cells maintained ln vitro in cell or tissue cultures.
Pyrogens must be removed from solutions or any product destined for injection (e.g. pharmaceuticals, e.g.
injectable saline, pharmacological drugs and lo antibiotics~ into humans or animals, or for use in the preparation of culture media for the propagation or mammalian cell or tissue cultures. Gram-negative ; bacterial lipopolysaccharides (LPS) (also termed "endotoxins"), a major constituent of the outer cell wall, are the main types of pyrogens encountered.
` Almost all Gram-negative bacteria found in nature - produce pyrogenic LPS, including (among numerous ~ others), Escherichia coli and Salmonella species.
-`~ Several methods have been developed for the removal of LPS pyrogens from solutions, including one method which is based on the affinity of the antibiotic ~ polymyxin B for the LPS molecule. Issekutz, in the .~ Journal of Immunological Methods (1983) 61: 275 - 281, described the use of polymyxin B covalently bound to agarose ~eads to remove LPS pyrogens from solutions in a packed column operation. However, the method for preparing the polymyxin-agarose support is laborious cl and may be subject to batch variations, si~ce it .~ involves chemical treatment in order to immobilize the polymyxin B on the agarose beads, and the extent and uniformity of the treatment may vary from batch-to-~'r batch. Such method is also costly, since the -~ ~aterials, quality control measures and chemical ~-1 treatments required are relatively expensive. Indeed, 3S products currently available on the market to remove pyrogens ~rom solutions are costly, and this cost in : 'f~ ~
.' :
., :.. , ' ~. . , : . , ' ' '.`~' . ' . . .. - ' ' ' ' ' ' . ' ' . ' . .' . , ~ ' ',: ' : .
,.. ' .. .'., ~' ... : ~ ' .. -,': .. ' . , ' ' ", - ' :
7 ~ ~
turn affects the cost of the final products (e.g.
pharmaceuticals) from which pyrogens must be removed.
Boehringer Mannheim has now provided polymyxin B-SEPHAROSE, namely polymyxin B bound covalently to 5SEPHAROSE 4B. This product is said to be available in gel form and is said to be able to remove endotoxin impurities. It is also said that the gel can be regenerated by washing with deoxycholate solutions.
This pyrogen removal agent su~fers from the same lodisadvantages as disclosed above with respect to the polymyxin B covalently bound to agarose beads. It is manifest that a commercially-attractive process cannot be conceived using this gel filter.
Alerchek Inc. has also now provided an affinity 15filter in the form of a derivatized PVC-silica composite with polymyxin B sulfate and an LPS binding co-peptide covalently immobilized to the silica.
Since this filter is microporous, filtering is effected using a tangential filter apparatus/ which is 20a more expensive technique.
An object of the broad aspect of this invention is the provision of a method for the removal of LPS
pyrogens fxom water in which the LPS pyrogen-removal agent can be prepared without the need for any 25chemical modification of the substrate used in such pyrogen removal.
An object of another aspect of this invention is the provision of a method for the removal of LPS pyrogens . from water in which the method for preparing such LPS
30pyrogen-removal agent is such that the quality of the LPS pyrogen-removal agent has minimal batch-to-batch variations.
An object of still another aspect of this invention is the provision of a method for the removal of LPS
~35pyrogens from ~ater in which the method for preparing -~such LPS pyrogen-removal agent is such that the LPS
, ., - , . . .
~ : . . -, . . ~ . .
stability of the LPS pyrogen-removal agent is enhanced.
An object of yet another aspect of this invention is the provision of a method for the removal of LPS
pyrogens from water in which the method is such that it enables the low cost preparation of such LPS
pyrogen-removal agent.
By a- broad aspect of this invention a method i5 provided for removing LPS pyrogens from an at~ueous solution which comprises passing such at~ueous solution through a filter consisting essentially of a macroporous hydrophobic cloth which has been coated with an oligopeptide, e.g. a polymyxin, preferably with polymyxin B, or with any other hydrophobic polypeptide, which is stably bound thereto.
- Polymyxin is an oligopeptide which has a high affinity for lipopolysaccharides (LPS) in aqueous buffers. Polymyxin is an antibody complex produced by Bacillus polymyxa:
'Y 1 2 L-DAB - D-X ~ L-Y
5 _ L-DAB -~L-Thr -~Z-~L-DAB
~-NH2 L-Thrt L-DA8- L-D
. ' = = I = ~
,," . y-NH2 'Y-NH2 DAB = ~ diaminobutyric acid ~ . .
~A Polymyxin B. Mixture of polymyxin~ Bl and B2.
~ 35 Polymyxin Bl. C56H~N16013 R = (+)-6-methyloctano-yl;
'~ X = phenylalanine; Y = leucine; Z = L-DAB.
~, PolYmyxin B2. C55~6N16013, R = 6-methylheptanoyl;
~, .
. 1 .
.
2 ~ 3 J 7 2 7 X = phenylalanine; Y = leucine; Z = L-DAB.
Polymyxin D1- CsoHs3N1s1s~ R = (+)-6-methyloctanoyl;
X ~ leucine; Y = threonine; Z = D-serine.
Polymyxin Dz~ C4~91N1sO,5. R = 6-mathylheptanoyl;
X = leucine; Y = threonone; Z = D-serine.
Colistin.
/L-DAB--D-L~u L-~ ,e~
L-D~a L-Thr ~ L-DA8 - L-DA8 1 0 = I = = I ~ ~ ~ :
; ~H2 ~-~2 L-Tllr-- L-D.~8~ L-D,~
~ H2 `~-~H2 DAB = o,~-diaminobutyric acJd .. .
Colistin A. Cs3H1ooN16013, polymyxin E1. R = (+)~6-methyloctanoyl.
; Polymyxin E C52H98N16O13. R = 6-methylheptanoyl.
The cloth is preferably formed from a hydrophobic fibre selected from the group consisting of polyester, polyethylene, polypropylene and nylon.
; It is preferred that the cloth be packed into an . .
upright cylindrical column fitted with a valve. The flow ratè used is from 25 to 200 ml/hr, but the rate preferably used is 50 ml/hr.
This invention also provides a filter comprising a macroporous hydrophobic cloth which has been coated with an oligopeptide, a hydrophobic polypeptide, or a ^ 30 polymyxin, thereby to have the oligopeptide, or the hydrophobic polypeptide the polymyxin stably bound thereto. Preferably the filter comprises a macroporous hydrophobic cloth which has been coated , with polymyxin B, thereby to have the polymyxin B
stably bound thereto. Still more preferably, the cloth is formed from a hydrophobic fibre selected from , . .
.~, .
. ...
:,~
., , :
~ . i . i ~ . , . .. . , , :
~ ~ 7 ri 2 1 the group consisting of polyester, polyethylene, polypropylene and nylon.
The term "macroporous" as applied to cloths when used herein is intended to mean textiles composed of hydrophobic synthetic polymeric fibres, which are either woven or non-woven into a physically structurally stable cloth of more than about 200 ~m thickness, such that the pores (i.e. spaces between the fibres) exceed about 20 ~m in diameter.
Macroporous cloths may be made substantially completely from synthetic fibres selected from the group consisting of polypropylene, polyethylene, nylon, and polyester.
Such macroporous cloths have the following characteristics: they can accommodate a larger volume of the oligopeptide, i.e. polymyxin, e.g. polymyxin B
per area; they have a larger surface area for binding to the oligopeptide, i.e. polymyxin, e.g. polymyxin B;
they have minimum flow resistance; and they have both strength and durability. Such macroporous cloths, by virtue of their hydrophobic characteristics, have been found to adsorb and absorb the oligopeptide, i.e.
polymyxin, e.g. polymyxin B since they provide a large surface area for the oligopeptide, i.e. polymyxin, e.g. polymyxin B ~apture. Macroporous cloths all have such minimum flow resistance.
Such macroporous hydrophobic cloths made of, e.g.
polypropylene and polyester, are readily commercially available and are moderately priced because of their large commercial demand as textiles and filters.
~acroporous 100% nylon cloth is commercially available ` as a generic product and may be acquired locally in the Ottawa, Canada area. Macroporous woven polyester cloth is commercially available as a generic product and may be acquired locally in the Ottawa, Canada area. Macroporous non-woven polypropylene filter cloth is available as a generic product and may be ' :
~ ., - . . . .
- ' . .:
;: ` - - . .
, 7 i~, ~
purchased from Aldrich Chemical Co. A variety of non-woven, macroporous polyester cloths may be obtained from DuPont, and are known by the trade-mark SONTARA.
One preferred embodiment of such SONTARA is SONTARA
5 81O0T~, which has the following chemical and physical characteristics.
Typical Physical Properties of SONTARA 8100 are:
(in English Units) U!JIT Tn'lC~NESSS~IE I G;lAEI ,.q~ OlD , .UU~ 'N ~ .q AIR ROLL SIZ`=
WEIGHT T_NSIL_ T--AP, D~URST ~ .IEA21UTr ~7-' ID COAQ
o:~ya i~) Imils) (Ibsl (Ib~ (P-i~ (CFMI~l~ in. 11n.
MO XD UO XD @ 05'~ ~,O) 0Ø yd S~yle .'~10tt~' Polyest~r - Frazier Air Permeability is described in ASTM D737-. 75, and is attached hereto as Appendix I.
20The term "hydrophobic" as applied to cloths when used herein is intended to mean that the cloths repel water, the degree of repelling being dependent on the - pore size and the inherent polymeric properties.
The term "non-woven" when referring to the cloth is 25intended to mean a cloth formed ~rom a random arrangement of natural or synthetic fibres by adhesives, heat and pressure, or needling techniques.
Polyester cloth can passively (hydrophobically) adsorb the oIigopeptide, i.e. plymyxin, e.g. polymyxin 303 using a simple coating procedure. Such -oligopeptide, i.e. polymyxin, e.g. polymyxin B-coated ~-cloth can effectively capture LPS antigens.
- Accordingly, by this invention it is now taught that -the oligopeptide, i.e. polymyxin, e.g. polymyxin B-35coated polyester cloth may be a suitable support in a method for the removal of LPS pyrogens from solutions.
-, ~. .
~.
., .
~772 ~ :
By the present invention, it has been found thatthe oligopeptide, i.e. polymyxin, e.g. polymyxin B-coated polyester cloth has several advantages over the use of other LPS pyrogen removal devices. Some advantages are (1) the ease with which polymyxin B-cloth can be prepared without the need for any chemical modifications of the cloth or the antibiotic;
(2) th`e minimum batch-to-batch variation in the guality of the oligopeptide, i.e. polymyxin, e.g.
polymyxin B-cloth preparation, due to the simple method for its preparation; (3) the stability of the oligopeptide, i.e. polymyxin e.g. polymyxin B-~ polyester cloth hydrophobic interaction; and (4) the -~ low cost of its preparation, which should help to reduce the commercial cost of pharmaceuticals or ~ther solutions to which it is applied.
It is also believed that other oligopeptides, e.g.
hydrophobic polypeptides which bind to LPS pyrogens would also bind to hydrophobic macroporous cloths to provide a filter for use in the method of this invention.
The following Examples are given with respect to the preparation of polymyxin B-coated cloth and the use of ` such cloth.
Polymyxin B sulfate (No. P-1004), Salmonella typhimurium lipopolysaccharide (LPS) (No. L-6511~ and ... .
-~ ~ the E-TOXATETM system for measuring LPS pyrogens (No.
210-A) were from Sigma Chemical Co.
Polyester cloths used were SONTARA obtained from ~; 30 DuPont and having the following characteristics:
: EXAMPLE A
Pre~aration of PolYmyxin-Coated Polyester Cloth ` All glassware used herein was de-pyrogenized by heating for 20 h at 250C~ Pyrogen-free distilled ' 35 water was used as a universal solvent.
Polyester cloth (DuPont, Sontara 8100~M) was cut into 6 x 6 mm segments and wetted by vigorously . ~i .. ; ' '. ', ' . ' ` ' . ' - - . -' . ' ' . ' ':: : ' ' . `., ' ' . ' ' :. .: ' . " ' "
: . , . ' , . . ` . .: ' ' ' ` ` . . :
i' ` '. ` : ' ', ' , ` ` ` . ::, ~ ~3 .~ h 1' sha~ing in doubly distilled water, and then blotted.
One gram of the cloth segments ("wet" weight) was placed in 5 ml of polymyxin B solution [10 mg polymyxin/ml in 0.01 M phosphate-buffered (pH 7 . 2~ -- 5 0.85% NaCl (PBS)] and incubated for 16 h at room temperature. The polymyxin-coated segments were then washed with 100 ml of PBS on a filter under suction and stored in P8S at 4C until use.
EXAMPLE I
Removal of_ LPS Pyroaens from Solution Usina Polymyxin-Coated Polyester Cloth one gram of polymyxin B-coated polyester cloth segments (prepared as Example A) was packed into a ' small disposable polypropylene QUIK-SEPTM column (Isolab. Inc., No. QS-U) fitted with a valve. A
solution of pyrogens consisting o~ Salmonella typhimurium LPS dissolved in PBS was then allowed to flow through the polymyxin B-cloth column by gravity flow, with the flow rate adjusted using the valve as requiredO The effluent from the column was c.ollected ', and its pyrogen content measured using the E-TOXATETM
~ kit for pyrogen detection according to the ','' manufacturer's directions.
EXAMPLE II
Effect of LPS Pyrogen Concentration on its Removal from Solution The ability of polymyxin B coated polyester cloth ~, to remove LPS pyrogens from solution was studied using ' polymyxin B-cloth packed into a column through which ' 30 the pyrogen solution could be "trickled" or filtered ', to effect the pyrogen removal. As an example, the removal of S. typhimurium LPS was studied.
Fifty millilitres of solutions containing various concentrations of S.,typhimurium LPS were passed at a ' 35 flow rate of 50 ml/h through a column packed with `' polymyxin B-cloth. The total effluent from the column was collected and then assayed for remaining LPS
' ':
. ~ .
':, ,,.: - . ' ~ ... . . ~ ,, - . , : . .
.. . , , ., . ,,, ~ , . . .. . .
. . . :, ., , .. , .. - ... : ~
-... : - . ~ :, .. . .. , .. , , . .. ~ ... ..
. . . ;: . :
., - , , .. . . . . . . . ..
J ri ~
pyrogen using the E-TOXATET~ kit. Table 1 shows that for input LPS concentrations of less than lO ~g/ml, the polymyxin B-cloth column efficiently removed the majority of the LPS from the solution. The LPS in the solution at an input concentration of 10 ~g/ml (or greater) might be more effectively removed by either decreasing the flow rate through the column or increasing the quantity of polymyxin B-cloth segments packed in the columnO
~ TABLE 1. Effect of LPS Pyroqen Concentration on its : Removal from Solution by Polymyxin-Coated Polyester Cloth : Input Effluent : 15 LPS Concentration LPS Concentration (~q/ml) (~q/ml) 0.1-1.0 2 < 0.05 ,~
1 < 0.05 0.1 < 0.05 EXAMPLE III
Effect of Flow Rate on the Removal of LPS Pyrogens ` from Solution .-It is expected that the rate at which the LPS
solution i5 passed through the polymyxin B-cloth `~ column will affect the efficiency of the column in . removing the LPS from solution. Therefore, the effect - of flow rate on LPS removal was studied.
Fifty millilitres of a 1 ~g/ml solution of LPS was 35 passed through the polymyxin B-cloth column at various flow rates, obtained by adjusting the valve on the .~ column as reguired. The effluent from the column was then collected and measured for LPS pyrogens as above.
Table 2 shows that a maximum flow rate of 50 ml/h achieved efficient removal of the LPS from solution, .~ -,.
.
. .
whereas flow rates greater than this resulted in some LPS remaining in the effluent solution. Since high flow rates would be desirable from the point of view of the time saved in LPS removal, the use of longer columns with more polymyxin B-cloth packing may be necessary to achieve more effective removal of the LPS
at the desired higher flow rates.
TABL~ 2. Effect of Flow Rate on the Removal of LPS
from Solution by Polymyxin-Cloth Flow Rate Effluent (ml/h LPS Concentration - (~q/ml) 200 0.1-10 - 15 100 0.1 < 0-05 < 0.05 .
These results demonstrate that polymyxin B-coated 20 polyester cloth is applicable to the removal of 1PS -pyrogens from solutions. This system was efficient, rapid and inexpensive, which should make it a commercially attractive alternative to other systems in current use. -~
Thus, by the present invention, macroporous polyester cloth coated with polymyxin B sulfate was packed into small plastic disposable columns, and solutions of phosphate-buffered saline containing various concentrations of S. tY~himurium 30 lipopolysaccharide pyrogens were filtered through the packed columns by gravity flow. Passage of the pyrogen solutions through the packed columns at a flow rate of 50 ml/h effectively removed the majority of the pyrogens from the solutions, as determined by the ', 35 limulus amoebocyte lysate detection system. Polymyxin B-coated macroporous hydrophobic cloth should be useful for the removal of pyrogens from pharmaceutical solutions (e.g. injectable solutions), cell culture .
.~ .
' ' . , ' ~ ' :
2 1~ ~ r~J 7 ~ ~
media and other solutions where the presence of pyrogens is undesirable.
"
... .
-~., .~' , ' ,i' .
. .
:,~
~ :
~ .
.~
~' ` .
. ~ . .
;:
~i i ~
~i . .
~ !
'`' . ~ . ~. ' , ' , ' ' . ' ' '"' ' '
Claims (9)
1. A method for removing LPS pyrogen from aqueous solution which method comprises: passing said aqueous solution through a filter comprising a macroporous hydrophobic cloth which has been coated with an oligopeptide, a hydrophobic polypeptide, or a polymyxin, thereby to have said oligopeptide, or said hydrophobic polypeptide said polymyxin stably bound thereto, whereby LPS pyrogens are adhered to said filter.
2. A method for removing LPS pyrogen from aqueous solution which method comprises: passing said aqueous solution through a filter comprising a macroporous hydrophobic cloth which has been coated with polymyxin B, thereby to have said polymyxin B stably bound thereto, whereby LPS pyrogens are adhered to said filter.
3. The method of claim 2 wherein said cloth is formed from a hydrophobic fibre selected from the group consisting of polyester, polyethylene, polypropylene and nylon.
4. The method of claim 2 wherein said cloth is packed into an upright cylindrical column provided with a control valve.
5. The method of claim 4 wherein the flow rate is 25 to 200 ml/hr.
6. The method of claim 5 wherein the flow rate is 50 ml/hr.
7. A filter comprising a macroporous hydrophobic cloth which has been coated with an oligopeptide, a hydrophobic polypeptide, or a polymyxin, thereby to have said oligopeptide, or said hydrophobic polypeptide said polymyxin stably bound thereto.
8. A filter comprising a macroporous hydrophobic cloth which has been coated with polymyxin B, thereby to have said polymyxin B stably bound thereto.
9. The filter of claim 8 wherein said cloth is formed from a hydrophobic fibre selected from the group consisting of polyester, polyethylene, polypropylene and nylon.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2037727 CA2037727A1 (en) | 1991-03-07 | 1991-03-07 | Removing lps pyrogen from aqueous solution |
| JP3113467A JPH04270965A (en) | 1990-05-18 | 1991-05-17 | Preparing method for oligopeptide adsorbing carrier and method for assay and removal for lipopolysaccharide using this method |
| US08/087,013 US5510242A (en) | 1990-05-18 | 1993-07-07 | Method for using polymyxin-coated substrate for lipopolysaccharide detection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2037727 CA2037727A1 (en) | 1991-03-07 | 1991-03-07 | Removing lps pyrogen from aqueous solution |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2037727A1 true CA2037727A1 (en) | 1992-09-08 |
Family
ID=4147146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2037727 Abandoned CA2037727A1 (en) | 1990-05-18 | 1991-03-07 | Removing lps pyrogen from aqueous solution |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2037727A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0608982A3 (en) * | 1993-01-21 | 1995-04-19 | Wako Pure Chem Ind Ltd | Process for inhibiting activity of endotoxin. |
| WO1995025808A1 (en) * | 1994-03-18 | 1995-09-28 | Boehringer Ingelheim International Gmbh | Process for treating eucaryotic cells |
-
1991
- 1991-03-07 CA CA 2037727 patent/CA2037727A1/en not_active Abandoned
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0608982A3 (en) * | 1993-01-21 | 1995-04-19 | Wako Pure Chem Ind Ltd | Process for inhibiting activity of endotoxin. |
| WO1995025808A1 (en) * | 1994-03-18 | 1995-09-28 | Boehringer Ingelheim International Gmbh | Process for treating eucaryotic cells |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2295302C (en) | Air purifying filter | |
| Boratyński et al. | Preparation of endotoxin-free bacteriophages | |
| US4606824A (en) | Modified cellulose separation matrix | |
| Ingavle et al. | Affinity binding of antibodies to supermacroporous cryogel adsorbents with immobilized protein A for removal of anthrax toxin protective antigen | |
| Petsch et al. | Membrane adsorbers for selective removal of bacterial endotoxin | |
| CA1195924A (en) | Depyrogenation process | |
| US20040050254A1 (en) | Air purifying filter using modified enzymes | |
| JP3670288B2 (en) | Density gradient filter | |
| CN100379481C (en) | Filter material for purifying air and manufacturing method thereof | |
| US6699386B2 (en) | Endotoxin adsorbent, and a method of removing endotoxin by using the same | |
| KR930000269B1 (en) | Membrane and Separation Method | |
| Petsch et al. | Selective adsorption of endotoxin inside a polycationic network of flat‐sheet microfiltration membranes | |
| Anspach et al. | Membrane adsorbers for selective endotoxin removal from protein solutions | |
| CA2037727A1 (en) | Removing lps pyrogen from aqueous solution | |
| JP2007203295A (en) | Air cleaning filter | |
| Petsch et al. | Endotoxin removal with poly (ethyleneimine)-immobilized adsorbers: Sepharose 4B versus flat sheet and hollow fibre membranes | |
| Machado et al. | Evaluation of a chitosan membrane for removal of endotoxin from human IgG solutions | |
| JP2006321791A (en) | Protein-carrying article, protein-carrying filter and method for producing them | |
| EP3866951A2 (en) | Filter medium, materials and methods for the removal of contaminants | |
| de Freitas et al. | Endotoxin removal from solutions of F (ab′) 2 fragments of equine antibodies against snake venom using macroporous chitosan membrane | |
| WO1984004696A1 (en) | Particle adsorption | |
| CN109078505A (en) | A kind of composite chromatography filter membrane and its preparation method and application containing adsorbing medium | |
| Hirayama et al. | Effect of the Pore Size of an A initiated Poly (γ-methyl l-glutamate) Adsorbent on the Selective Removal of Endotoxin | |
| WO2000016897A1 (en) | Microfiltration filter layer for separating endotoxins and the use of said microfiltration filter layer | |
| CA2037726A1 (en) | Wound dressing of hydrophobic macroporous cloth and oligopeptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |